There is so much interest in Cynata's lead Cymerus™ mesenchymal stem cell (MSC) product, and we
are in bed with 2 multi billion companies, and the clinical trial with MHRA, which is only a formality,
and if the trial had any chance of being negative, Fuji would have waited for confirmation.
And this has created HUGE interest in the stem cell industry.
I can see $2 by dec - jan
Cynata. How high, how soon?, page-16
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
-0.015(7.32%) |
Mkt cap ! $34.30M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.0¢ | 19.0¢ | $6.137K | 32.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 133917 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 10.02am 03/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |